Antihyperglycemic effects of ginseng and possible mechanisms

Drugs of the Future

Volumn 33, Issue 6, 2008, Pages 507-514

  Peng, D C ^a   Chen, W P ^b   Xie, J T ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b Tianjin Research Institute of Building Science   (China)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIDIABETIC AGENT; CARBOXYLIC ACID; ESSENTIAL OIL; GINSENG EXTRACT; GINSENG POLYSACCHARIDE; GINSENG SAPONIN; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RH 2; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; MINERAL; ORGANONITROGEN DERIVATIVE; PANAXADIOL; PANAXAN I; PANAXAN J; PANAXAN K; PANAXAN L; PEPTIDE; PHYTOSTEROL; PLACEBO; PLANT EXTRACT; UNINDEXED DRUG; VITAMIN;

CARBOHYDRATE METABOLISM; CHEMICAL COMPOSITION; CLINICAL TRIAL; DIABETES MELLITUS; DRUG DETERMINATION; DRUG EFFICACY; DRUG MECHANISM; ENERGY EXPENDITURE; FRUIT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; PLANT LEAF; PLANT ROOT; REVIEW; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION;

EID: 51749113105     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2008.033.06.1188424     Document Type: Review

References (96)

1. Skyler, J.S. Diabetes mellitus: Pathogenesis and treatment strategies. J Med Chem 2004, 47(17): 4113-7.
2. Cho, W.C., Yip, T.T., Chung, W.S., Lee, S.K., Leung, A.W., Cheng, C.H., Yue, K.K. Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDI-TOF MS. J Ethnopharmacol 2006, 108(2): 272-9.
3. Jia, W., Gao, W.Y., Xiao, P.G. Antidiabetic drugs of plant origin used in China: Compositions, pharmacology, and hypoglycemic mechanisms. Zhongguo Zhong Yao Za Zhi 2003, 28(2): 108-13.
4. Vuksan, V., Sievenpiper, J.L. Herbal remedies in the management of diabetes: Lessons learned from the study of ginseng. Nutr Metab Cardiovasc Dis 2005, 15(3): 149-60.
5. Xie, J.T., McHendale, S., Yuan, C.S. Ginseng and diabetes. Am J Chin Med 2005, 33(3): 397-404.
6. Huang, K.C. The Pharmacology of Chinese Herbs. CRC Press, Boca Raton, 1999, 17-44.
7. Morgan, A., Cupp, M.J. Panax ginseng. In: Toxicology and Clinical Pharmacology of Herbal Products, M.J. Cupp (Ed.). Humana Press, Totowa, 2002, 141-53.
8. Ackerknecht, E.H. A Short History of Medicine. Johns Hopkins University Press, Baltimore/London, 1982.
9. Cheung, S.C., Kwan, P.S., Kong, Y.C. Introduction to Pents'ao Stud. Chinese University Press, Hong Kong, 1983, 162-4.
10. Phillipson, J.D., Anderson, L.A. Ginseng - Quality, safety and efficacy? Pharmacol J 1984, 232: 161-5.
11. Blumenthal, M., Goldberg, A., Brinckmann, J. Ginseng Root. Integrative Medicine Communications, Newton, 2000, 170-7.
12. Attele, A.S., Wu, J.A., Yuan, C.S. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 1999, 58(11): 1685-93.
13. Barnes, A.S., Powell-Griner, E., McFann, K., Nahin, R.L. Complementary and alternative medicine use among adults. Adv Data 2004, 343: 1-19.
14. Helms, S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004, 9(3): 259-74.
15. Lee, F.C. Facts About Ginseng. Hollyn International Corp., Elizabeth, 1992, 1-8.
16. Gillis, C.N. Panax ginseng pharmacology: A nitric oxide link? Biochem Pharmacol 1997, 54(1): 1-8.
17. Xie, J.-T., Attele, A.S., Yuan, C.-S. Ginseng: Beneficial and potential adverse effect. In: A Textbook of Complementary and Alternative Therapies. C.-S. Yuan, E. Beiber, B.A. Bauer (Eds.). CRC Press, Boca Raton/London/New York/Washington, D.C., 2006, 71-89.
18. Saito, H., Tsuchiya, M., Naka, S., Takagi, K. Effects of Panax ginseng root on conditioned avoidance response in rats. Jpn J Pharmacol 1977, 27(4): 509-16.
19. Benishin, C.G., Lee, R., Wang, L.C., Liu, H.J. Effects of ginsenoside Rb1 on central cholinergic metabolism. Pharmacology 1991, 42(4): 223-9.
20. Zhao, R., McDaniel, W. Ginseng improves strategic learning by normal and brain-damaged rat. Neuroreport 1998, 9(7): 1619-24.
21. Lopez, M.V., Cuadrado, M.P., Ruiz-Poveda, O.M., Del Fresno, A.M., Accame, M.E. Neuroprotective effect of indiviual ginsenosides on astropytes primary culture. Biochim Biophys Acta 2007, 1770(9): 1308-16.
22. Yoshizato, H., Fujikawa, T., Shibata, M., Tanaka, M., Nakashima, K. Stimulation of growth hormone gene expression in the pituitary and brain by Panax ginseng C. A. MEYER. Endocr J 1999, 46(Suppl.): S85-8.
23. Broadhurst, C.L., Polansky, M.M., Anderson, R.A. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem 2000, 48(3): 849-52.
24. Lee, D.C., Lee, M.O., Kim, C.Y., Clifford, D.H. Effect of ether, ethanol and aqueous extracts of ginseng on cardiovascular function in dogs. Can J Comp Med 1981, 45(2): 182-7.
25. Inoue, M., Wu, C.Z., Dou, D.Q., Chen, Y.J., Ogihara, Y. Lipoprotein lipase activation by red ginseng saponins in hyperlipidemia model animals. Phytomedicine 1999, 6(4): 257-65.
26. Jiang, Q.S., Huang, X.N., Dai, ZX, Yang, G.Z., Zhou, Q.X., Shi, J.S., Wu, Q. Inhibitory effect of ginsenoside Rb1 on cardiac hypertrophy induced by monocrotaline in rat. J Ethnopharmacol 2007, 111(3): 567-72.
27. Yokozawa, T., Zhou, J., Hattori, M., Inaba, S., Okada, T., Oura, H. Effects of ginseng in nephrectomized rats. Biol Pharm Bull 1994, 17(11): 1485-9.
28. Kim, H.Y., Kang, K.S., Yamabe, N., Nagai, R., Yokozawa, T. Protective effect of heat-processed American ginseng against diabetic renal damage in rats. J Agric Food Chem 2007, 55(21): 8491-7.
29. Sun, X.B., Matsumoto, T., Kiyohara, H., Hirano, M., Yamada, H. Cytoprotective activity of pectic polysaccharides from the root of Panax ginseng. J Ethnopharmacol 1991, 31(1): 101-7.
30. Kase, Y., Saitoh, K., Makino, B., Hashimoto, K., Ishige, A., Komatsu, Y. Relationship between the antidiarrhoeal effects of Hange-Shashin-To and its active components. Phytother Res 1999, 13(6): 468-73.
31. Chen, X., Lee, T.J. Ginsenosides-induced nitric oxide-mediated relaxation of the rabbit corpus cavernosum. Br J Pharmacol 1995, 115(1): 15-8.
32. Tamler, R., Mechanick, J.I. Dietary supplements and nutraceuticals in the management of andrologic disorders. Endocrinol Metab Clin North Am 2007, 36(2): 533-52.
33. Gaffney, B.T., Hugel, H.M., Rich, P.A. Panax ginseng and Eleutherococcus senticosus may exaggerate an already existing biphasic response to stress via inhibition of enzymes which limit the binding of stress hormones to their receptors. Med Hypotheses 2001, 56(5): 567-72.
34. Wang, B.X., Zhou, Q.L., Yang, M., Wang, Y., Cui, Z.Y., Liu, Y.Q., Ikejima, T. Hypoglycemic activity of ginseng glycopeptide. Acta Pharmacol Sin 2003, 24(1): 50-4.
35. Wang, B.X., Zhou, Q.L., Yang, M., Wang, Y., Cui, Z.Y., Liu, Y.Q., Ikejima, T. Hypoglycemic mechanism of ginseng glycopeptide. Acta Pharmacol Sin 2003, 24(1): 61-6.
36. Rajput, Z.I., Hu, S.H., Xiao, C.W., Arijo, A.G. Adjuvant effects of saponins on animal immune responses. J Zhejiang Univ Sci B 2007, 8(3): 153-61.
37. Banerjee, U., Izquierdo, J.A. Antistress and antifatigue properties of Panax ginseng: Comparison with piracetam. Acta Physiol Lat Am 1982, 32(4): 277-85.
38. Lee, S.H., Jung, B.H., Kim, S.Y., Lee, E.H., Chung, B.C. The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine level under immobilization stress. Pharmacol Res 2006, 54(1): 46-9.
39. Guan, S., Ge, M. Experimental study on anti-fatigue effect of shenfu injection on diaphragmatic muscle]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000, 20(5): 359-61.
40. Yun, Y., Lee, Y., Jo, S., Jung, I.S. Inhibition of autochthonous tumor by ethanol insoluble fraction from Panax ginseng as an immunomodulator. Planta Med 1993, 59(6): 521-4.
41. Mochizuki, M., Yoo, Y.C., Matsuzawa, K. et al. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull 1995, 18(9): 1197-202.
42. Hasegawa, H., Saiki, I. Cancer Prevention by Ginseng via Its Intestinal Bacterial Metabolites. Art Village Inc., Tokyo, 2003, 16-26.
43. Yue, P.Y., Mak, N.K., Cheng, Y.K. et al. Pharmacogenomics and the Yin/ Yang actions of ginseng: Anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med 2007, 2: 6.
44. Cho, Y.K., Sung, H., Lee, H.J., Joo, C.H., Cho, G.J. Long-term intake of Korean red ginseng In HIV-1-intected patients: Development of resistance mutation to zidovudine is delayed. Int Immunopharmacol 2001, 1(7): 1295-305.
45. Maffei Facino, R., Carini, M., Aldini, G., Berti, F., Rossoni, G. Panax ginseng administration in the rat prevents myocardial ischemia-reperfusion damage induced by hyperbaric oxygen: Evidence for an antioxidant intervention. Planta Med 1999, 65(7): 614-9.
46. Guan, L., Li, W., Liu, Z. Effect of ginsenoside-Rb1 on cardiomyocyte apoptosis after ischemia and reperfusion in rats. J Huazhong Univ Sci Technolog Med Sci 2002, 22(3): 212-5.
47. Kim, H., Chen, X., Gillis, C.N. Ginsenosides protect pulmonary vascular endothelium against free radical-induced injury. Biochem Biophys Res Commun 1992, 189(2): 670-6.
48. Sohn, H.O., Lim, H.B., Lee, Y.G., Lee, D.W., Kim, Y.T. Effect of subchronic administration of antioxidants against cigarette smoke exposure in rats. Arch Toxicol 1993, 67(10): 667-73.
49. Shao, Z.H., Xie, J.T., Vanden Hoek, T.L. et al. Antioxidant effects of American ginseng berry extract in cardiomyopytes exposed to acute oxidant stress. Biochim Biophys Acta 2004, 1670(3): 165-71.
50. Cho, W.C., Chung, W.S., Lee, S.K., Leung, A.W., Cheng, C.H., Yue, K.K. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol 2006, 550(1-3): 173-9.
51. Banthorpe, D.V. Terpenoids. In: Natural Products: Their Chemistry and Biological Significance. J Mann et al. (Eds.). Longman Scientific and Technical, Essex, 1994, 331-9.
52. Kim, Y.S., Kim, D.S., Kim, S.I. Ginsenoside Rh2 and Rh3 induce differentiation of HL-60 cells into granulocytes: Modulation of protein kinase C isoforms during differentiation by ginsenoside Rh2. Int J Biochem Cell Biol 1998, 30(3): 327-38.
53. Ota, T., Fujikawa-Yamamoto, K., Zong, Z.P. et al. Plant-glycoside modulation of cell surface related to control of differentiation in cultured B16 melanoma cells. Cancer Res 1987, 47(14): 3863-7.
54. Ourisson, G., Crabbe, P., Rodic, O.R. Tetracyclic Triterpenes. Holden-Day Publisher, San Francisco, 1964.
55. Harkey, M.R., Henderson, G.L., Gershwin, M.E., Stern, J.S., Hackman, R.M. Variability in commercial ginseng products: An analysis of 25 preparations. Am J Clin Nutr 2001, 73(6): 1101-6.
56. Xie, J.T., Zhou, Y.-P., Dey, L. et al. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 2002, 9(3): 254-8.
57. Xie, J.T., Mehendale, S.R., Wang, A., Han, A.H., Wu, J.A., Osinski, J., Yuan, C.-S. American ginseng leak Ginsenoside analysis and hypoglycemic activity. Pharmacol Res 2004, 49(2): 113-7.
58. Waki, I., Kyo, H., Yasuda, M., Kimura, M. Effects of a hypoglycemic component of ginseng radix on insulin biosynthesis in normal and diabetic animals. J Pharmacobiodyn 1982, 5(8): 547-54.
59. Xie, J.T., Wang, C.Z., Wang, A.B., Wu, J., Basila, D., Yuan, C.S. Antihyperglycemic effects of total ginsenosides from leaves and stem of Panax ginseng. Acta Pharmacol Sin 2005, 26(9): 1104-10.
60. Shafrir, E. Animal models of non-insulin-dependent diabetes. Diabetes Metab Rev 1992, 8(3): 179-208.
61. Attele, A.S., Zhou, Y.P., Xie, J.T. et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002, 51(6): 1851-8.
62. Xie, J.T., Aung, H.H., Wu, J.A., Attele, A.S., Yuan, C.S. Effects of American ginseng berry extract on blood glucose levels in ob/ob mice. Am J Chin Med 2002, 30(2-3): 187-94.
63. Dey, L., Zhang, L., Yuan, C.S. Anti-diabetic and anti-obese effects of ginseng berry extract: Comparison between intraperitoneal and oral administrations. Am J Chin Med 2002, 30(4): 645-7.
64. Dey, L., Xie, J.T., Wang, A., Wu, J., Maleckar, S.A., Yuan, C.S. Anti-hyperglycemic effects of ginseng: Comparison between root and berry. Phytomedicine 2003, 10(6-7): 600-5.
65. Xie, J.T., Wu, J.A., Mehendale, S., Aung, H.H., Yuan, C.S. Anti-hyperglycemic effect of the polysaccharides fraction from American ginseng berry extract in ob/ob mice. Phytomedicine 2004, 11(2-3):182-7.
66. Xie, J.T., Wang, C.Z., Ni, M., Wu, J.A., Mehendale, S.R., Aung, H.H., Yuan, C.S. American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice. J Food Sci 2007, 72(8): S590-4.
67. Verspohl, E.J. Recommended testing in diabetes research. Planta Med 2002, 68(7): 581-90.
68. Wing, R.R., Blair, E.H., Bononi, P., Marcus, M.D., Watanabe, R., Bergman, R.N. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 1994, 17(1): 30-6.
69. Kimura, M., Waki, I., Tanaka, O., Nagai, Y., Shibata, S. Pharmacological sequential trials for the fractionation of components with hypoglycemic activity in alloxan diabetic mice from ginseng radix. J Pharmacobiodyn 1981, 4(6): 402-9.
70. Kimura, M., Suzuki, J. The pattern of action of blended Chinese traditional medicines to glucose tolerance curves in genetically diabetic KK-CAy mice. J Pharmacobiodyn 1981, 4(12): 907-15.
71. Molokovskii, D.S., Davydov, V.V., Tiulenev, V.V. Deistvie adaptogennykh fitopreparatov pri eksperimental'nom alloksanovom diabete. Probl Endokrinol (Mosk) 1989, 35(6): 82-7.
72. Kimura, M., Suzuki, J. The pattern of action of blended Chinese medicine to glucose tolerance curves in genetically diabetic KK-CAy mice. J Pharmacobiodyn 1981, 4(12): 907-15.
73. Miller, L.G. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998, 158(20): 2200-11.
74. World Health Organization. Radix Ginseng. In: WHO Monographs on Selected Medicinal Plants, Vol. 1. Malta, Geneva, 1999, 168-82.
75. Oshima, Y., Konno, C., Hikino, H. Isolation and hypoglycemic activity of panaxans I, J, K and L, glycans of Panax ginseng roots. J Ethnopharmacol 1985, 14(2-3): 255-9.
76. Vuksan, V., Sievenpiper, J.L., Koo, V.Y., Francis, T., Beljan-Zdravkovic, U., Xu, Z., Vidgen, E. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 2000, 160(7): 1009-13.
77. Vuksan, V., Stavro, M.P., Sievenpiper, J.L., Beljan-Zdravkovic, U., Leiter, L.A., Josse, R.G., Xu, Z. Similar post-prandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 2000, 23(9): 1221-6.
78. Vuksan, V., Sung, M.K., Sievenpiper, J.L. et al. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: Results of a randomized, doubleblind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis 2008, 18(1): 46-56.
79. Konno, C., Sugiyama, K., Kano, M., Takahashi, M., Hikino, H. Isolation and hypoglycaemic activity of panaxans A, B, C, D and E, glycans of Panax ginseng roots. Planta Med 1984, 50(5): 434-6.
80. Ng, T.B., Yeung, H.W. Hypoglycemic constituents of Panax ginseng. Gen Pharmacol 1985, 16(6): 549-52.
81. Konno, C., Murakami, M., Oshima, Y., Hikino, H. Isolation and hypoglycemic activity of panaxans Q, R, S, T and U, glycans of Panax ginseng roots. J Ethnopharmacol 1985, 14(1): 69-74.
82. Oshima, Y., Sato, K., Hikino, H. Isolation and hypoglycemic activity of quinquefolans A, B, and C, glycans of Panax quinquefolium roots. J Nat Prod 1987, 50(2): 188-90.
83. Chung, S.H., Choi, C.G., Park, S.H. Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch Pharm Res 2001, 24(3): 214-8.
84. Davydov, V.V., Molokovskii, D.S., Limarenko, A. Efficacy of ginseng drugs in experimental insulin-dependent diabetes and toxic hepatitis. Patol Fiziol Eksp Ter 1990, (5): 49-52.
85. Yuan, C.S., Wu, J.A., Lowell, T., Gu, M. Gut and brain effects of American ginseng root on brainstem neuronal activities in rats. Am J Chin Med 1998, 26(1): 47-55.
86. Suzuki, Y., Ito, Y., Konno, C., Furuya, T. Effects of tissue cultured of ginseng on gastric secretion and pepsin activity.] Yakugaku Zasshi 1991, 111(12): 770-4.
87. Rotshteyn, Y., Zito, S.W. Application of modified in vitro screening procedure for identifying herbals possessing sulfonyl-urea-like activity. J Ethnopharmacol 2004, 93(2-3): 337-44.
88. Lee, W.K., Kao, S.T., Liu, I.M., Cheng, J.T. Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats. Horm Metab Res 2007, 39(5): 347-54.
89. Luo, J.Z., Luo, L. American ginseng stimulates insulin production and prevents apoptosis through regulation of uncoupling protein-2 in cultured beta cells. Evid Based Complement Alternat Med 2006, 3(3): 365-72.
90. Ohnishi, Y., Takagi, S., Miura, T. et al. Effect of ginseng radix on GLUT2 protein content in mouse liver in normal and epinephrine-induced hyperglycemic mice. Biol Pharm Bull 1996, 19(9): 1238-40.
91. Yuan, C.S., Attele, A.S., Wu, J.A., Liu, D. Modulation of American ginseng on brainstern GABAergic effects in rats. J Ethnopharmacol 1998, 62(3): 215-22.
92. Xie, J.T., Mehendale, S. R., Li, X. et al. Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta 2005, 1740(3): 319-25.
93. Kitts, D.D., Wijewickreme, A.N., Hu, C. Antioxidant properties of a North American ginseng extract. Mol Cell Biochem 2000, 203(1-2): 1-10.
94. Evans, J.L., Goldfine, I.D., Maddux, B.A., Grodsky, G.M. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 2002, 23(5): 599-622.
95. Shao, Z., Xie, J., Vande Hoek, T. et al. Antioxidant effects of American ginseng berry extract in cardiomyocytes exposed to acute oxidant stress. Biochem Biophys Acta 2004, 1670(3): 165-71.
96. Roy, D., Perreault, M., Marette, A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol 1998, 274(4, Pt. 1): E692-9.